{"id":773511,"date":"2023-07-28T10:08:24","date_gmt":"2023-07-28T14:08:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/"},"modified":"2023-07-28T10:08:24","modified_gmt":"2023-07-28T14:08:24","slug":"mink-to-provide-second-quarter-2023-financial-report-and-corporate-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/","title":{"rendered":"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update"},"content":{"rendered":"<div class=\"mw_release\">\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Company announces participation in BTIG Virtual Biotechnology Conference<\/li>\n<\/ul>\n<p align=\"left\">NEW YORK, July  28, 2023  (GLOBE NEWSWIRE) &#8212; MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that the company will release its second quarter 2023 financial results via press release before the market opens on Thursday, Aug. 10.<\/p>\n<p>In addition, MiNK Chief Executive Officer and President Jennifer Buell, Ph.D., will participate in and provide an update on the progress of the company\u2019s portfolio at the following upcoming investor conference:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>BTIG Virtual Biotechnology Conference 2023<\/strong> \u2013 A fireside chat will be held virtually on Tuesday, Aug. 8, at 11:30 a.m. ET.<\/li>\n<\/ul>\n<p>A replay of the fireside chat from the BTIG conference will be accessible on the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZX9YL2G1xP1CmNgcNh65f49nRxIs1LNCg1KgR3TaXKyB5JrsSb06CQGQq19Qs5JinqG-r69bulf8-TjRrOxF0ndRikJu9C3EsWUeiLlLNOn3CqoBmSarmUZk0SsgoK66OwMSIwr8BsusEM88BVNv6fsKESOkJhEldIAXxnb0gqq9VJwkAqMLHJnMSsBC2sBZbbQj1Zpw1zoDIzIAJ9BESw==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investor.minktherapeutics.com\/events-and-presentations<\/a> following the event.<\/p>\n<p>\n        <strong>About MiNK Therapeutics<\/strong>\n      <\/p>\n<p>MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery, development and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next-generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. The company is headquartered in New York, New York. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZX9YL2G1xP1CmNgcNh65f6iLn6KdTAmu7AE8VIhHsa6FXN44Hy6XmEh4Vd1y-D6F10sAfqBDM7rfoJS62hAzmBmVWAGOj1_fkXP9EfKvU5fwOT3qu8vIzgWgukbiaAqv\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/minktherapeutics.com\/<\/a>. Follow us on Twitter @MiNK_iNKT.<\/p>\n<p>\n        <strong>Investor Contact<\/strong>\n      <\/p>\n<p>Zack Armen<\/p>\n<p>917-362-1370<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wJDWgTaUbYD6sEwS0xDCNI0NRmyBsqvl7w1_Friia8t0C00FkNdz9ksTnEiP-x-PahPvWNINy3_E3RlUALPWP_WPoTj8xHNOYNdMhJSXpAi3zyjLi9YWl0wmuSHKBUqN\" rel=\"nofollow noopener\" target=\"_blank\">investors@minktherapeutics.com<\/a>\n      <\/p>\n<p>\n        <strong>Media Contact<\/strong>\n      <\/p>\n<p>Alexa Buffa<\/p>\n<p>781-674-4428<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tJ8y4xkpbzkm1WqkszOorJqlMPWMDJhGjNY7663C63rjUZ0t9dZYA_VjSXXmZmXswfhS9p-cobm3nySieZRhjsv7B9iNIWelqeb9g-hW3opZGJonkfDaEw7lh3WxEEaTEQWYOwF0aZPTqfhDwizAzw==\" rel=\"nofollow noopener\" target=\"_blank\">communications@minktherapeutics.com<\/a>\n      <\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NmU5MmRmYWEtYWM5Ni00NTgyLTkzMGUtZTE3YjE1N2JiY2NkLTEyMzQ3NjQ=\/tiny\/MiNK-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Company announces participation in BTIG Virtual Biotechnology Conference NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) &#8212; MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that the company will release its second quarter 2023 financial results via press release before the market opens on Thursday, Aug. 10. In addition, MiNK Chief Executive Officer and President Jennifer Buell, Ph.D., will participate in and provide an update on the progress of the company\u2019s portfolio at the following upcoming investor conference: BTIG Virtual Biotechnology Conference 2023 \u2013 A fireside chat will be held virtually on Tuesday, Aug. 8, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-773511","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company announces participation in BTIG Virtual Biotechnology Conference NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) &#8212; MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that the company will release its second quarter 2023 financial results via press release before the market opens on Thursday, Aug. 10. In addition, MiNK Chief Executive Officer and President Jennifer Buell, Ph.D., will participate in and provide an update on the progress of the company\u2019s portfolio at the following upcoming investor conference: BTIG Virtual Biotechnology Conference 2023 \u2013 A fireside chat will be held virtually on Tuesday, Aug. 8, &hellip; Continue reading &quot;MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-28T14:08:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update\",\"datePublished\":\"2023-07-28T14:08:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/\"},\"wordCount\":254,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/\",\"name\":\"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=\",\"datePublished\":\"2023-07-28T14:08:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/","og_locale":"en_US","og_type":"article","og_title":"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update - Market Newsdesk","og_description":"Company announces participation in BTIG Virtual Biotechnology Conference NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) &#8212; MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that the company will release its second quarter 2023 financial results via press release before the market opens on Thursday, Aug. 10. In addition, MiNK Chief Executive Officer and President Jennifer Buell, Ph.D., will participate in and provide an update on the progress of the company\u2019s portfolio at the following upcoming investor conference: BTIG Virtual Biotechnology Conference 2023 \u2013 A fireside chat will be held virtually on Tuesday, Aug. 8, &hellip; Continue reading \"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-28T14:08:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update","datePublished":"2023-07-28T14:08:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/"},"wordCount":254,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/","name":"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=","datePublished":"2023-07-28T14:08:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MjU0MiM1NzE0MDA1IzIyMjMyMTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mink-to-provide-second-quarter-2023-financial-report-and-corporate-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/773511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=773511"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/773511\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=773511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=773511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=773511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}